Sensitive, inflamed and eczema-prone skin needs barrier support with evidence-based botanical formulations
R&D Focus
Plant biotechnology, ethnobotany, microbiome support, barrier function and eczema care
Innovative Solution
Bia and Antü formulas combine plant-biotech complexes with barrier-support and inflammation-focused topical and supplement protocols
Solution Effectiveness
Two peer-reviewed open-label adult studies reported up to 99% SCORAD reduction at eight weeks, 79% without itch, 78% higher hydration and 40% lower transepidermal water loss in one protocol; no randomized comparator was used
Investment Funding
Last Funding Stage
Seed
Total Funding Amount
$25.2M
Startup Stage
Early Stage
Lead Investors
Target Accelerator, Sekhmet Ventures
People
Founders
Barbara Paldus
CEO
Barbara Paldus
About
Codex Labs is a bioscience skin health company
Products
Product
Bia Eczema products, Antü products, cleansers, lotions and supplements; customer reviews are available on official and retailer sites
Star Product
Bia Eczema protocol, because it has the most specific patent and peer-reviewed clinical support
Demo Product or Complete Product?
Complete commercial skincare and eczema-support line
Future Plan
Market Expansion
Continues to expand clinical, professional and retail distribution
Awards and Recognitions
Participations
Presented clinical work through dermatology research and professional meetings, including pediatric eczema work announced for SPD 2026
Media Apperance
Covered by clinical, beauty and biotechnology media
Something missing or incorrect on this page? Help us enrich this information
